Physician profile
William S Hirsch
NPI 1679555320
$5,641.17
in general payments reported to CMS, 2019-2025
38 companies · $1,215 in 2025
The $1,215 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,568 · 2020: $336 · 2021: $624 · 2022: $634 · 2023: $473 · 2024: $791 · 2025: $1,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,479.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $802.72 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $411.30 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $355.06 | 2019-2021 | |
| Novo Nordisk INC | $317.70 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Boston Scientific Corporation | $311.72 | 2019-2025 | Watchman Access System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $306.49 | 2019-2025 | Lifevest |
| Pfizer INC. | $287.99 | 2019-2025 | |
| Amarin Pharma, INC. | $265.63 | 2019-2022 | |
| Scpharmaceuticals INC. | $238.79 | 2023-2025 | |
| Abbott Laboratories | $198.99 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $190.89 | 2021-2025 | Verquvo, Capvaxive |
| Akcea Therapeutics, INC. | $183.07 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $175.46 | 2019-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $169.20 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $153.48 | 2019-2025 | Farxiga, Wainua |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.